MidMarketNow
Get the Weekly

Enodia Therapeutics

—

SectorsHealthcare1
Regions—
Last activity

Activity, last 12 months

Enodia Therapeutics — events per month, last 12 months
Enodia Therapeutics — events per month, last 12 months
MonthEvents
August 20250
September 20250
October 20250
November 20250
December 20250
January 20260
February 20260
March 20261
April 20260
May 20260
June 20260
July 20260

Deal history

  1. Enodia buys Kezar assets in EUR 118.52m deal

    Enodia Therapeutics has agreed to acquire assets from Kezar Life Sciences for EUR 118.52 million. The transaction underscores continued demand for de-risked pipelines as biotechs recycle capital and sharpen focus.

We use privacy-respecting product analytics to understand how readers use MidMarketNow and improve it. No personal data (email, IP) is sent. See our privacy policy.